• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CREP2 CREATININE PLUS VER.2; ENZYMATIC METHOD, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CREP2 CREATININE PLUS VER.2; ENZYMATIC METHOD, CREATININE Back to Search Results
Catalog Number 03263991190
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/24/2017
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).(b)(4).(b)(6).
 
Event Description
The customer stated that they received high results for controls and approximately 300 patient samples tested for crep2 creatinine plus ver.2 (crep) on a cobas 6000 c (501) module - c501.All initial results from these samples were reported outside of the laboratory to the physician.Patient result and control outliers were detected by the customer after their second daily control cycle.Controls were elevated up to about 100%.The customer replaced the reagent cassette and repeated all samples with crep results higher than 1 mg/dl.Upon repeat, the initial results were found to be almost 100-200% higher.The customer provided an example of one patient sample that had an erroneous result that was reported outside of the laboratory.The sample initially resulted as 22.00 mg/dl and when repeated using the new reagent cassette, it resulted as 0.3 mg/dl.The reagent cassette that was in use at the time of the event was placed on the analyzer as a standby cassette.No controls were tested on the cassette prior to use.The affected control and patient values occurred only with this one cassette.The physician was informed about the event and the repeated values.The physician recognized that the values were not plausible.There was no allegation that a patient was adversely affected.The c501 analyzer serial number was (b)(4).The field service engineer checked the reagent pipettor, sample pipettor, and wash unit.He checked the gear pump pressure and it was constant.Tubing was found to be in good condition.On the day of the event, a system reagent bottle was found to be bent and it was replaced.The engineer placed the affected reagent cassette back on the analyzer and measured some patient samples that were within the reference range (below 1 mg/dl).He found the patient results to be 100-200% higher when running these on the affected cassette.The reagent cassette was provided for investigation where it was determined that a reagent bottle in the cassette was contaminated with either creatinine or a substance that reacts with the reagent.It is assumed that the contaminant reaction with the reagent within the bottle had progressed.It was determined that there was no calibration performed on the cassette in question, so the issue with the cassette was not detected.A retention reagent cassette was checked and performance of retention reagent met specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CREP2 CREATININE PLUS VER.2
Type of Device
ENZYMATIC METHOD, CREATININE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key6417452
MDR Text Key70426409
Report Number1823260-2017-00581
Device Sequence Number1
Product Code JFY
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K024098
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other
Type of Report Initial
Report Date 03/20/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/20/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2017
Device Catalogue Number03263991190
Device Lot Number20313801
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/15/2017
Date Manufacturer Received01/26/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-